STIMULATE-ICP-CAREINEQUAL study protocol: Defining usual care and examining inequalities in Long Covid support, 2022, Ramasawmy et al

Discussion in 'Long Covid research' started by Andy, Aug 16, 2022.

  1. Andy

    Andy Committee Member

    Messages:
    22,400
    Location:
    Hampshire, UK
    Full title: STIMULATE-ICP-CAREINEQUAL (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways) study protocol: Defining usual care and examining inequalities in Long Covid support

    Abstract

    Introduction
    Individuals with Long Covid represent a new and growing patient population. In England, fewer than 90 Long Covid clinics deliver assessment and treatment informed by NICE guidelines. However, a paucity of clinical trials or longitudinal cohort studies means that the epidemiology, clinical trajectory, healthcare utilisation and effectiveness of current Long Covid care are poorly documented, and that neither evidence-based treatments nor rehabilitation strategies exist. In addition, and in part due to pre-pandemic health inequalities, access to referral and care varies, and patient experience of the Long Covid care pathways can be poor. In a mixed methods study, we therefore aim to: (1) describe the usual healthcare, outcomes and resource utilisation of individuals with Long Covid; (2) assess the extent of inequalities in access to Long Covid care, and specifically to understand Long Covid patients’ experiences of stigma and discrimination.

    Methods and analysis
    A mixed methods study will address our aims. Qualitative data collection from patients and health professionals will be achieved through surveys, interviews and focus group discussions, to understand their experience and document the function of clinics. A patient cohort study will provide an understanding of outcomes and costs of care. Accessible data will be further analysed to understand the nature of Long Covid, and the care received.

    Ethics and dissemination
    Ethical approval was obtained from South Central—Berkshire Research Ethics Committee (reference 303958). The dissemination plan will be decided by the patient and public involvement and engagement (PPIE) group members and study Co-Is, but will target 1) policy makers, and those responsible for commissioning and delivering Long Covid services, 2) patients and the public, and 3) academics.

    Open access, https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0271978
     
    RedFox and Peter Trewhitt like this.
  2. Andy

    Andy Committee Member

    Messages:
    22,400
    Location:
    Hampshire, UK

Share This Page